Results 291 to 300 of about 1,626,160 (308)

SGLT2 inhibition — a novel strategy for diabetes treatment

Nature Reviews Drug Discovery, 2010
Robert R Henry, Henry Robert R
exaly  

Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes

Nature Reviews Drug Discovery, 2011
Frank Waldron-Lynch, Kevan C Herold, Herold Kevan C   +2 more
exaly  

Trends in type 2 diabetes

BMJ, 2019
Mike, Lean, Louise, McCombie, Joe, McSorely   +2 more
openaire   +2 more sources

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

New England Journal of Medicine, 1993
D M Nathan, P Cleary, Carolyn Siebert
exaly  

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine, 2008
Stephen Macmahon, John Chalmers, Bruce Neal   +2 more
exaly  

Type 2 diabetes as an inflammatory disease

Nature Reviews Immunology, 2011
Marc Y Donath, Steven E Shoelson, Donath Marc Y   +2 more
exaly  

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

New England Journal of Medicine, 2015
Bernard Zinman, Christoph Wanner, John M Lachin   +2 more
exaly  

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

New England Journal of Medicine, 2001
Jaana Lindstr̈Om, Johan G Eriksson, T T Valle   +2 more
exaly  

Effects of Intensive Glucose Lowering in Type 2 Diabetes

New England Journal of Medicine, 2008
Hertzel C Gerstein, Robert P Byington, J Thomas Bigger   +2 more
exaly  

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine, 2016
Steven P Marso, Agostino Consoli, Esteban Jódar   +2 more
exaly